For: | Elzagheid A, Ålgars A, Bendardaf R, Lamlum H, Ristamaki R, Collan Y, Syrjanen K, Pyrhonen S. E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome. World J Gastroenterol 2006; 12(27): 4304-4309 [PMID: 16865770 DOI: 10.3748/wjg.v12.i27.4304] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i27/4304.htm |
Number | Citing Articles |
1 |
Sarah F. Becker, Rahul Langhe, Chaolie Huang, Doris Wedlich, Jubin Kashef. Giving the right tug for migration: Cadherins in tissue movements. Archives of Biochemistry and Biophysics 2012; 524(1): 30 doi: 10.1016/j.abb.2012.02.013
|
2 |
Marjolaine A. Pelissier-Rota, Nicolas T. Chartier, Muriel R. Jacquier-Sarlin. Intercellular Communication in Cancer. 2015; : 53 doi: 10.1007/978-94-017-7380-5_4
|
3 |
Hibiki Udagawa, Genichiro Ishii, Masahiro Morise, Shigeki Umemura, Shingo Matsumoto, Kiyotaka Yoh, Seiji Niho, Hironobu Ohmatsu, Masahiro Tsuboi, Koichi Goto, Atsushi Ochiai, Yuichiro Ohe. Comparison of the expression levels of molecular markers among the peripheral area and central area of primary tumor and metastatic lymph node tumor in patients with squamous cell carcinoma of the lung. Journal of Cancer Research and Clinical Oncology 2015; 141(8): 1417 doi: 10.1007/s00432-015-1912-7
|
4 |
Abdelbaset Buhmeida, Riyad Bendardaf, Marja Hilska, Yrjö Collan, Matti Laato, Stina Syrjänen, Kari Syrjänen, Seppo Pyrhönen. Prognostic Significance of Matrix Metalloproteinase-9 (MMP-9) in Stage II Colorectal Carcinoma. Journal of Gastrointestinal Cancer 2009; 40(3-4) doi: 10.1007/s12029-009-9091-x
|
5 |
Imen Miladi-Abdennadher, Rania Abdelmaksoud-Dammak, Dorra Ben Ayed-Guerfali, Lobna Ayadi, Abdelmajid Khabir, Ali Amouri, Foued Frikha, Nabil Tahri, Sameh Ellouz, Mounir Frikha, Tahia Sellami-Boudawara, Raja Mokdad-Gargouri. Expression of COX-2 and E-cadherin in Tunisian patients with colorectal adenocarcinoma. Acta Histochemica 2012; 114(6): 577 doi: 10.1016/j.acthis.2011.11.002
|
6 |
Taghrid Bengallo. Expression of E-Cadherin in Prostatic Carcinoma: Prognostic Significance. Journal of Cancer Prevention & Current Research 2016; 4(3) doi: 10.15406/jcpcr.2016.04.00119
|
7 |
Atsushi TOYOFUKU, Yuki KOREEDA, Yugo IHA, Kohei YOSHIDA, Aiichiro HIGURE, Takakazu SASAGURI, Naoki NAGATA. A Case of Rectosigmoid Colon Cancer with Tumor Thrombus in the Inferior Mesenteric Vein. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2021; 82(8): 1550 doi: 10.3919/jjsa.82.1550
|
8 |
Wafaey Gomaa, Haneen Al-Maghrabi, Jaudah Al-Maghrabi. The prognostic significance of immunostaining of Wnt signaling pathway molecules, E-cadherin and β-catenin in Colorectal Carcinoma. Arab Journal of Gastroenterology 2021; 22(2): 137 doi: 10.1016/j.ajg.2021.05.001
|
9 |
Thomas U. Ahearn, Aasma Shaukat, W. Dana Flanders, Robin E. Rutherford, Roberd M. Bostick. A Randomized Clinical Trial of the Effects of Supplemental Calcium and Vitamin D3 on the APC/β-Catenin Pathway in the Normal Mucosa of Colorectal Adenoma Patients. Cancer Prevention Research 2012; 5(10): 1247 doi: 10.1158/1940-6207.CAPR-12-0292
|
10 |
Kaibin Chang, Lei Jiang, Yifeng Sun, He Li. Effect of E-cadherin on Prognosis of Colorectal Cancer: A Meta-Analysis Update. Molecular Diagnosis & Therapy 2022; 26(4): 397 doi: 10.1007/s40291-022-00593-3
|
11 |
Nao Aramaki, Genichiro Ishii, Eiji Yamada, Masahiro Morise, Keiju Aokage, Motohiro Kojima, Tomoyuki Hishida, Junji Yoshida, Norihiko Ikeda, Masahiro Tsuboi, Atsushi Ochiai. Drastic morphological and molecular differences between lymph node micrometastatic tumors and macrometastatic tumors of lung adenocarcinoma. Journal of Cancer Research and Clinical Oncology 2016; 142(1): 37 doi: 10.1007/s00432-015-1996-0
|
12 |
Amanda M Clark, Bo Ma, D Lansing Taylor, Linda Griffith, Alan Wells. Liver metastases: Microenvironments andex-vivomodels. Experimental Biology and Medicine 2016; 241(15): 1639 doi: 10.1177/1535370216658144
|
13 |
Clare Verrill, Lucia Cerundolo, Chad Mckee, Michael White, Christiana Kartsonaki, Eve Fryer, Emma Morris, Simon Brewster, Indrika Ratnayaka, Luke Marsden, Hans Lilja, Ruth Muschel, Xin Lu, Freddie Hamdy, Richard J. Bryant. Altered expression of epithelial-to-mesenchymal transition proteins in extraprostatic prostate cancer. Oncotarget 2016; 7(2): 1107 doi: 10.18632/oncotarget.6689
|
14 |
E. M. Paltseva, A. V. Varlamov, M. I. Sekacheva, D. N. Fedorov, O. G. Skipenko. Impact of preoperative drug therapy on adhesion molecule expression in colorectal cancer liver metastases. Arkhiv patologii 2015; 77(3): 10 doi: 10.17116/patol201577310-16
|
15 |
Adam Elzagheid, Abdelbaset Buhmeida, Eija Korkeila, Yrjö Collan, Kari Syrjänen, Seppo Pyrhönen. Nuclear β-catenin expression as a prognostic factor in advanced colorectal carcinoma. World Journal of Gastroenterology 2008; 14(24): 3866-3871 doi: 10.3748/wjg.14.3866
|
16 |
Adam Elzagheid, Abdelbaset Buhmeida, Eija Korkeila, Yrjö Collan, Kari Syrjänen, Seppo Pyrhönen. Up-regulation of α-catenin is associated with increased lymph node involvement in colorectal cancer. World Journal of Gastroenterology 2008; 14(31): 4903-4908 doi: 10.3748/wjg.14.4903
|
17 |
MEIYING JI, EUN JEOUNG LEE, KI BAE KIM, YANGMI KIM, ROHYUN SUNG, SANG-JEON LEE, DON SOO KIM, SEON MEE PARK. HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells. Oncology Reports 2015; 33(5): 2299 doi: 10.3892/or.2015.3879
|
18 |
Adam Elzagheid, Fatma Emaetig, Abdelbaset Buhmeida, Matti Laato, Omran El-Faitori, Kari Syrjänen, Yrjö Collan, Seppo Pyrhönen. Loss of MUC2 expression predicts disease recurrence and poor outcome in colorectal carcinoma. Tumor Biology 2013; 34(2): 621 doi: 10.1007/s13277-012-0588-8
|
19 |
María Virtudes Céspedes, María Jesús Larriba, Miguel Angel Pavón, Patricia Álamo, Isolda Casanova, Matilde Parreño, Anna Feliu, Francesc Josep Sancho, Alberto Muñoz, Ramón Mangues. Site-Dependent E-Cadherin Cleavage and Nuclear Translocation in a Metastatic Colorectal Cancer Model. The American Journal of Pathology 2010; 177(4): 2067 doi: 10.2353/ajpath.2010.100079
|
20 |
Elsayed I Salim, Mona M Hegazi, Jin Seok Kang, Hager M Helmy. Expression Patterns of Cancer Stem Cell Markers During Specific Celecoxib Therapy in Multistep Rat Colon Carcinogenesis Bioassays. Asian Pacific Journal of Cancer Prevention 2016; 17(3): 1023 doi: 10.7314/APJCP.2016.17.3.1023
|
21 |
Jingchun Jin, Tiefeng Jin, Meiling Quan, Yingshi Piao, Zhenhua Lin. Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma. Diagnostic Pathology 2012; 7(1) doi: 10.1186/1746-1596-7-135
|
22 |
Yuan‐Chiang Chung, Wan‐Chen Wei, Chia‐Nung Hung, Jen‐Fang Kuo, Chih‐Ping Hsu, King‐Jen Chang, Wei‐Ting Chao. Rab11 collaborates E‐cadherin to promote collective cell migration and indicates a poor prognosis in colorectal carcinoma. European Journal of Clinical Investigation 2016; 46(12): 1002 doi: 10.1111/eci.12683
|
23 |
R A Bartolomé, R Barderas, S Torres, M J Fernandez-Aceñero, M Mendes, J García-Foncillas, M Lopez-Lucendo, J I Casal. Cadherin-17 interacts with α2β1 integrin to regulate cell proliferation and adhesion in colorectal cancer cells causing liver metastasis. Oncogene 2014; 33(13): 1658 doi: 10.1038/onc.2013.117
|
24 |
Yuan-Chiang Chung, Jang-Fang Kuo, Wan-Chen Wei, King-Jen Chang, Wei-Ting Chao, Ming Tan. Caveolin-1 Dependent Endocytosis Enhances the Chemosensitivity of HER-2 Positive Breast Cancer Cells to Trastuzumab Emtansine (T-DM1). PLOS ONE 2015; 10(7): e0133072 doi: 10.1371/journal.pone.0133072
|
25 |
Meriem Khiari, Amira Arfaoui, Lilia Kriaa, Inés Chaar, Sameh Amara, Med Amine Lounis, Souraya Sammoud, Monia Dhraeif, Lassaad Gharbi, Sabeh Mzabi-Regaya, Saadia Bouraoui. The Prognostic Value of the Immunohistochemical Expression and Mutational Pattern of the Key Mediator of Wnt Signaling. Applied Immunohistochemistry & Molecular Morphology 2012; 20(1): 62 doi: 10.1097/PAI.0b013e31821a20c2
|
26 |
Nidhi Mishra, Samipta Singh, Priyanka Maurya, Raquibun Nisha, Shubhini A. Saraf. Nanoformulations in Human Health. 2020; : 133 doi: 10.1007/978-3-030-41858-8_7
|
27 |
Ge-Liang Liu, Han-Jie Yang, Tian Liu, Yun-Zhao Lin. Expression and significance of E-cadherin, N-cadherin, transforming growth factor-β1 and Twist in prostate cancer. Asian Pacific Journal of Tropical Medicine 2014; 7(1): 76 doi: 10.1016/S1995-7645(13)60196-0
|
28 |
Aleksandra Djikic Rom, Sandra Dragicevic, Radmila Jankovic, Sanja Radojevic Skodric, Predrag Sabljak, Velimir Markovic, Jovana Rosic Stojkovic, Goran Barisic, Aleksandra Nikolic. Markers of Epithelial–Mesenchymal Transition and Mucinous Histology Are Significant Predictors of Disease Severity and Tumor Characteristics in Early-Onset Colorectal Cancer. Diagnostics 2024; 14(14): 1512 doi: 10.3390/diagnostics14141512
|
29 |
Atsushi TOYOFUKU, Katsushi FUJIMOTO, Yugo IHA, Hiroaki KURODA, Aiichiro HIGURE, Hirokazu SASAGURI, Naoki NAGATA. Two Cases of Portsite Recurrence after Laparoscopic Surgery for Colorectal Cancer. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2020; 81(8): 1583 doi: 10.3919/jjsa.81.1583
|
30 |
Ning Li, Xiaobing Chen, Xiangbin Wan, Suxia Luo, Lili Han, Mengqiang Zhou, Dengwen Yin, Li Zhang. Relationship between expression of CEA, E-cadherin and liver metastasis in colorectal cancer. Chinese Journal of Clinical Oncology 2008; 5(6): 429 doi: 10.1007/s11805-008-0429-0
|
31 |
Adam Elzagheid, Eija Korkeila, Riyad Bendardaf, Abdelbaset Buhmeida, Suvi Heikkilä, Antti Vaheri, Kari Syrjänen, Seppo Pyrhönen, Olli Carpén. Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer. Human Pathology 2008; 39(12): 1737 doi: 10.1016/j.humpath.2008.04.020
|
32 |
Abd AlRahman M. Foda, Azza AbdelAziz, Amira K. El-Hawary, Ali Hosni, Khalid R. Zalata, Asmaa I. Gado. Mucinous Colorectal Adenocarcinoma. Applied Immunohistochemistry & Molecular Morphology 2015; 23(7): 506 doi: 10.1097/PAI.0000000000000112
|
33 |
Serena Marchiò, Marco Soster, Sabrina Cardaci, Andrea Muratore, Alice Bartolini, Vanessa Barone, Dario Ribero, Maria Monti, Paola Bovino, Jessica Sun, Raffaella Giavazzi, Sofia Asioli, Paola Cassoni, Lorenzo Capussotti, Piero Pucci, Antonella Bugatti, Marco Rusnati, Renata Pasqualini, Wadih Arap, Federico Bussolino. A complex of α6 integrin and E‐cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin‐like 6. EMBO Molecular Medicine 2012; 4(11): 1156 doi: 10.1002/emmm.201101164
|
34 |
Jienan Kong, Chunchan Di, Junjie Piao, Jie Sun, Longzhe Han, Liyan Chen, Guanghai Yan, Zhenhua Lin. Ezrin contributes to cervical cancer progression through induction of epithelial-mesenchymal transition. Oncotarget 2016; 7(15): 19631 doi: 10.18632/oncotarget.7779
|
35 |
Wu-Ching Uen, Cheng-Jeng Tai, Shing-Chuan Shen, Woan-Ruoh Lee, Tang-Yi Tsao, Win-Ping Deng, Hung-Yi Chiou, Chung-Huei Hsu, Cheng-I Hsieh, Ching-Fong Liao, Ming-Chung Jiang. Differential distributions of CSE1L/CAS and E-cadherin in the polarized and non-polarized epithelial glands of neoplastic colorectal epithelium. Journal of Molecular Histology 2010; 41(4-5): 259 doi: 10.1007/s10735-010-9286-2
|
36 |
Yong-Quan Chu, Zai-Yuan Ye, Hou-Quan Tao, Yuan-Yu Wang, Zhong-Sheng Zhao. Relationship between cell adhesion molecules expression and the biological behavior of gastric carcinoma. World Journal of Gastroenterology 2008; 14(13): 1990-1996 doi: 10.3748/wjg.14.1990
|
37 |
A. BUHMEIDA, A. ELZAGHEID, A. ÅLGARS, Y. COLLAN, K. SYRJÄNEN, S. PYRHÖNEN. Expression of the cell‐cell adhesion molecule β‐catenin in colorectal carcinomas and their metastases. APMIS 2008; 116(1): 1 doi: 10.1111/j.1600-0463.2008.00754.x
|
38 |
Hui‐Ping Hsu, Yan‐Shen Shan, Ying‐Tai Jin, Ming‐Derg Lai, Pin‐Wen Lin. Loss of E‐cadherin and β‐catenin is correlated with poor prognosis of ampullary neoplasms. Journal of Surgical Oncology 2010; 101(5): 356 doi: 10.1002/jso.21493
|
39 |
Alexandros Drivalos, Michael Chrisofos, Eleni Efstathiou, Amalia Kapranou, Gerasimos Kollaitis, Georgios Koutlis, Nick Antoniou, Dimitrios Karanastasis, Meletios A. Dimopoulos, Aristotelis Bamias. Expression of α5-integrin, α7-integrin, Ε-cadherin, and N-cadherin in localized prostate cancer. Urologic Oncology: Seminars and Original Investigations 2016; 34(4): 165.e11 doi: 10.1016/j.urolonc.2015.10.016
|
40 |
Konstantinos A. Paschos, David Canovas, Nigel C. Bird. The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis. Cellular Signalling 2009; 21(5): 665 doi: 10.1016/j.cellsig.2009.01.006
|
41 |
A. Buhmeida, R. Bendardaf, M. Hilska, J. Laine, Y. Collan, M. Laato, K. Syrjänen, S. Pyrhönen. PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma. Annals of Oncology 2009; 20(7): 1230 doi: 10.1093/annonc/mdn783
|
42 |
Suzhan Zhang. Multidisciplinary Management of Liver Metastases in Colorectal Cancer. 2017; : 93 doi: 10.1007/978-94-017-7755-1_6
|
43 |
Bassma Mohamed El Sabaa, Walid Ossman Arafat, Walid Abdel Maksoud. Study of the expression of Survivin in relation to E-Cadherin and their significance in colorectal carcinoma. An immunohistochemical and clinicopathological study. Egyptian Journal of Pathology 2011; 31(2): 37 doi: 10.1097/01.XEJ.0000406590.87075.6c
|
44 |
Adam R. Markowski, Konstancja Ustymowicz, Anna J. Markowska, Wiktoria Romańczyk, Katarzyna Guzińska-Ustymowicz. E-Cadherin Expression Varies Depending on the Location within the Primary Tumor and Is Higher in Colorectal Cancer with Lymphoid Follicles. Cancers 2023; 15(12): 3260 doi: 10.3390/cancers15123260
|
45 |
Suresh Govatati, Gopi Krishna Singamsetty, Nayudu Nallabelli, Sravanthi Malempati, Pasupuleti Sreenivasa Rao, Venkata Kranthi Kumar Madamchetty, Sowdamani Govatati, Rudramadevi Kanapuram, Nagesh Narayana, Manjula Bhanoori, Kondaiah Kassetty, Varadacharyulu Nallanchakravarthula. Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) alterations to colorectal cancer susceptibility: a case–control study. Tumor Biology 2014; 35(12): 12059 doi: 10.1007/s13277-014-2505-9
|
46 |
ADAM ELZAGHEID, ABDELBASET BUHMEIDA, MATTI LAATO, OMRAN EL‐FAITORI, KARI SYRJÄNEN, YRJÖ COLLAN, SEPPO PYRHÖNEN. Loss of E‐cadherin expression predicts disease recurrence and shorter survival in colorectal carcinoma. APMIS 2012; 120(7): 539 doi: 10.1111/j.1600-0463.2011.02863.x
|
47 |
Abd Al-Rahman Mohammad Foda, Mie Ali Mohammad, Azza Abdel-Aziz, Amira Kamal El-Hawary. Relation of glypican-3 and E-cadherin expressions to clinicopathological features and prognosis of mucinous and non-mucinous colorectal adenocarcinoma. Tumor Biology 2015; 36(6): 4671 doi: 10.1007/s13277-015-3115-x
|
48 |
Angela Distaso, Luca Abatangelo, Rosalia Maglietta, Teresa Maria Creanza, Ada Piepoli, Massimo Carella, Annarita D’Addabbo, Sayan Mukherjee, Nicola Ancona. Knowledge-Based Intelligent Information and Engineering Systems. Lecture Notes in Computer Science 2008; 5178: 206 doi: 10.1007/978-3-540-85565-1_26
|
49 |
Zsuzsanna Pap, Zoltán Pávai, Lóránd Dénes, Ilona Kovalszky, János Jung. An Immunohistochemical Study of Colon Adenomas and Carcinomas: E-cadherin, Syndecan-1, Ets-1. Pathology & Oncology Research 2009; 15(4): 579 doi: 10.1007/s12253-009-9157-x
|
50 |
Aleksandar Bogdanovic, Jovana Despotovic, Danijel Galun, Nemanja Bidzic, Aleksandra Nikolic, Jovana Rosic, Zoran Krivokapic. Prognostic Significance of CDH1, FN1 and VIM for Early Recurrence in Patients with Colorectal Liver Metastasis After Liver Resection. Cancer Management and Research 2021; : 163 doi: 10.2147/CMAR.S287974
|
51 |
Petra Jurčić, Petra Radulović, Melita Balja, Milan Milošević, Božo Krušlin. E‑cadherin and NEDD9 expression in primary colorectal cancer, metastatic lymph nodes and liver metastases. Oncology Letters 2019; doi: 10.3892/ol.2019.9917
|
52 |
Curtis J. Wray, Ami N. Shah, Russell S. Berman, Syed A. Ahmad. Liver Metastases. 2009; : 1 doi: 10.1007/978-1-84628-947-7_2
|
53 |
Bo Yang, Lin Cao, Jiaen Liu, Yanjie Xu, Gillian Milne, Wanhei Chan, Steven D. Heys, Colin D. McCaig, Jin Pu. Low expression of chloride channel accessory 1 predicts a poor prognosis in colorectal cancer. Cancer 2015; 121(10): 1570 doi: 10.1002/cncr.29235
|
54 |
Yuan-Chiang Chung, Wan-Chen Wei, Shin-Han Huang, Chi-Min Shih, Chih-Ping Hsu, King-Jen Chang, Wei-Ting Chao. Rab11 regulates E-cadherin expression and induces cell transformation in colorectal carcinoma. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-587
|